| 000 | 01529nam a22003017i 4500 | ||
|---|---|---|---|
| 005 | 20250819182753.0 | ||
| 008 | 250731s2021 nyua|||fr|||| 001 0 eng d | ||
| 020 | _a9781639272396 | ||
| 040 |
_aEG-GaU _cEG-GaU _dEG-GaU _erda |
||
| 082 | 0 | 4 |
_223 _a616.047 _bP.P.A |
| 245 | 1 | 0 |
_aPeroxisome Proliferator Activated Receptors : _bFrom Basic Science to Clinical Applications / _cEdited by Mark Taylor. |
| 250 | _aFirst edition. | ||
| 264 | 1 |
_aNew York : _bAmerican Medical Publishers, _c2021. |
|
| 300 |
_a195 pages : _billustrations ; _c28 cm. |
||
| 336 |
_2rdacontent _atext _btxt |
||
| 337 |
_2rdamedia _aunmediated _bn |
||
| 338 |
_2rdacarrier _avolume _bnc |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | _aThis book explores peroxisome proliferator activated receptors (PPARs), their role as nuclear receptor proteins regulating gene expression, cellular differentiation, development, and tumorigenesis. It covers the clinical applications of PPAR agonists in metabolic syndrome management, including blood sugar and triglyceride reduction. It provides updated global research and insights into PPAR biology and therapeutic potential. | ||
| 650 | 0 |
_aPeroxisome proliferator _xactivated receptors. _960950 |
|
| 650 | 0 |
_aNuclear receptors. _960951 |
|
| 650 | 0 |
_aMetabolic syndrome. _960952 |
|
| 650 | 0 |
_aMolecular biology. _960945 |
|
| 650 | 0 |
_aPharmacology. _960941 |
|
| 700 | 1 |
_aTaylor, Mark, _eeditor. _960953 |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c11316 _d11316 |
||